Variable efficacy of the non-covalent KRAS<sup>G12D</sup> inhibitor (MRTX-1133) with obesity in murine pancreatic cancer.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2026-06-08
DOI
https://doi.org/10.1038/s41698-026-01493-z
Primary Topic
Peptidase Inhibition and Analysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Variable efficacy of the non-covalent KRASG12D inhibitor (MRTX-1133) with obesity in murine pancreatic cancer.

Lyse A. Norian, Henry Nnaemeka Ogbonna, Jianqing Zhang, Pia Muri et al.
PubMed
Peptidase Inhibition and Analysis
article

Variable efficacy of the non-covalent KRASG12D inhibitor (MRTX-1133) with obesity in murine pancreatic cancer.

Lyse A. Norian, Henry Nnaemeka Ogbonna, Jianqing Zhang, Pia Muri, Dhana Sekar Reddy Bandi, Karen Aikhionbare, Cherlene Hardy, J B Foote, Sujith Sarvesh, Ganji Purnachandra Nagaraju, Bassel F El-Rayes, Holly Stephens
article en

Abstract

No abstract available for this paper.
PubMed
University of Kentucky (US), University of Alabama at Birmingham (US), University of California San Diego Medical Center (US)
Good health and well-being
Openalex Percentile: Top 7%
Peptidase Inhibition and Analysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.